COMPOUND COMPRISING A MAO TARGETING/SEEKER MOIETY FOR TREATING HUMAN GLIOMAS

Research output: Patent

S Baskin, David (Inventor), Alun Sharpe, Martyn (Inventor)

Disclosed are compound for targeting chemotherapeutic agents to mammalian mitochondria. Also disclosed are monoamine oxidase compositions, and methods of using them for the selective therapy of mammalian cancers, and in particular, in the treatment of human gliomas. Also disclosed are methods employing the novel targeted chemotherapeutics with one or more conventional anti-cancer therapies, including, for example, radiotherapy.

Original languageEnglish (US)
Patent numberCA2887928
IPCA61K 31/ 4375 A I
Priority date10/31/12
StatePublished - Oct 10 2013

Cite this

Standard

COMPOUND COMPRISING A MAO TARGETING/SEEKER MOIETY FOR TREATING HUMAN GLIOMAS. / Baskin, David, S (Inventor); Sharpe, Martyn, Alun (Inventor).

IPC No.: A61K 31/ 4375 A I. Patent No.: CA2887928.

Research output: Patent

Harvard

Baskin, David, S & Sharpe, Martyn, A 2013, COMPOUND COMPRISING A MAO TARGETING/SEEKER MOIETY FOR TREATING HUMAN GLIOMAS, Patent No. CA2887928, IPC No. A61K 31/ 4375 A I.

APA

Baskin, David, S., & Sharpe, Martyn, A. (2013). IPC No. A61K 31/ 4375 A I. COMPOUND COMPRISING A MAO TARGETING/SEEKER MOIETY FOR TREATING HUMAN GLIOMAS. (Patent No. CA2887928).

Vancouver

Baskin, David S, Sharpe, Martyn A, inventors. COMPOUND COMPRISING A MAO TARGETING/SEEKER MOIETY FOR TREATING HUMAN GLIOMAS. A61K 31/ 4375 A I. 2013 Oct 10.

Author

Baskin, David, S (Inventor) ; Sharpe, Martyn, Alun (Inventor). / COMPOUND COMPRISING A MAO TARGETING/SEEKER MOIETY FOR TREATING HUMAN GLIOMAS. IPC No.: A61K 31/ 4375 A I. Patent No.: CA2887928.

BibTeX

@misc{d97435f433f34e7982e9b128140d09ed,
title = "COMPOUND COMPRISING A MAO TARGETING/SEEKER MOIETY FOR TREATING HUMAN GLIOMAS",
abstract = "Disclosed are compound for targeting chemotherapeutic agents to mammalian mitochondria. Also disclosed are monoamine oxidase compositions, and methods of using them for the selective therapy of mammalian cancers, and in particular, in the treatment of human gliomas. Also disclosed are methods employing the novel targeted chemotherapeutics with one or more conventional anti-cancer therapies, including, for example, radiotherapy.",
author = "{Baskin, David}, S and {Sharpe, Martyn}, Alun",
year = "2013",
month = "10",
day = "10",
language = "English (US)",
type = "Patent",
note = "CA2887928; A61K 31/ 4375 A I",

}

RIS

TY - PAT

T1 - COMPOUND COMPRISING A MAO TARGETING/SEEKER MOIETY FOR TREATING HUMAN GLIOMAS

AU - Baskin, David, S

AU - Sharpe, Martyn, Alun

PY - 2013/10/10

Y1 - 2013/10/10

N2 - Disclosed are compound for targeting chemotherapeutic agents to mammalian mitochondria. Also disclosed are monoamine oxidase compositions, and methods of using them for the selective therapy of mammalian cancers, and in particular, in the treatment of human gliomas. Also disclosed are methods employing the novel targeted chemotherapeutics with one or more conventional anti-cancer therapies, including, for example, radiotherapy.

AB - Disclosed are compound for targeting chemotherapeutic agents to mammalian mitochondria. Also disclosed are monoamine oxidase compositions, and methods of using them for the selective therapy of mammalian cancers, and in particular, in the treatment of human gliomas. Also disclosed are methods employing the novel targeted chemotherapeutics with one or more conventional anti-cancer therapies, including, for example, radiotherapy.

M3 - Patent

M1 - CA2887928

ER -

Similar Research Outputs

  1. Successful Treatment of Intracranial Glioblastoma Xenografts With a Monoamine Oxidase B-Activated Pro-Drug

    Sharpe, M. A., Livingston, A. D., Gist, T. L., Ghosh, P., Han, J. & Baskin, D. S., Sep 1 2015, In : EBioMedicine. 2, 9, p. 1122-1132 11 p.

    Research output: Contribution to journalArticle

ID: 33565224